ACADIA Pharmaceuticals Inc. Free Cash Flow 2009–2025
ACADIA Pharmaceuticals Inc. reported $105.15M of free cash flow for fiscal 2025. That was 33.1% lower than fiscal 2024. Compared with fiscal 2020, the change was +173.1%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $105.15M | -33.1% |
| FY 2024 | $157.20M | +844.0% |
| FY 2023 | $16.65M | +114.6% |
| FY 2022 | $-114.03M | +10.1% |
| FY 2021 | $-126.78M | +11.8% |
| FY 2020 | $-143.75M | +5.6% |
| FY 2019 | $-152.26M | +10.2% |
| FY 2018 | $-169.57M | +22.4% |
| FY 2017 | $-218.57M | -4.1% |
| FY 2016 | $-209.91M | -69.4% |
| FY 2015 | $-123.94M | -86.1% |
| FY 2014 | $-66.61M | -105.7% |
| FY 2013 | $-32.39M | -49.7% |
| FY 2012 | $-21.63M | -8.7% |
| FY 2011 | $-19.90M | -85.9% |
| FY 2010 | $-10.70M | +22.0% |
| FY 2009 | $-13.73M | — |
Source: ACADIA Pharmaceuticals Inc. SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open ACAD 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
ACADIA Pharmaceuticals Inc. reported $105.15M of free cash flow for fiscal 2025. That was 33.1% lower than fiscal 2024. Compared with fiscal 2020, the change was +173.1%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for ACADIA Pharmaceuticals Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeACADIA Pharmaceuticals Inc. — frequently asked questions
What is ACADIA Pharmaceuticals Inc.'s free cash flow?
ACADIA Pharmaceuticals Inc. (ACAD) reported free cash flow of $105.15M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from ACADIA Pharmaceuticals Inc.'s official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.